{
    "2018-05-04": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Value Stocks for Income Investors",
                "features": {
                    "keywords": [
                        "Value",
                        "Stocks",
                        "Income",
                        "Investors"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "Pharma Stock Roundup: Mixed Q1 for MRK, PFE, FDA Nod for Kymriah's 2nd Indication",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "MRK",
                        "PFE",
                        "FDA",
                        "Kymriah",
                        "Indication"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "Is Gilead Sciences Stock Finally a Bargain?",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Sciences",
                        "Stock",
                        "Bargain"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Gilead Sciences, Inc. Stock Will Recoverâ€¦ Eventually",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Sciences",
                        "Stock",
                        "Recover",
                        "Eventually"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}